Dr. Michael Cochran, PhD

Director of Chemistry at Avidity Biosciences

Speaker

Scientist with over ten years of experience in industry developing antibody-oligonucleotide conjugates, nanoparticles, and antigen-adjuvant conjugates to improve treatments for rare muscular diseases, oncology, and vaccines. At Avidity, Michael has worked on the chemistry of antibody-siRNA and PMO conjugates from preclinical discovery through GMP manufacturing.